Parkman Healthcare Partners’s Silence Therapeutics SLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-401,746
| Closed | -$1.13M | – | 101 |
|
|
2025
Q1 | $1.13M | Sell |
401,746
-89,334
| -18% | -$252K | 0.13% | 83 |
|
|
2024
Q4 | $3.38M | Sell |
491,080
-6,790
| -1% | -$46.7K | 0.45% | 57 |
|
|
2024
Q3 | $9.05M | Buy |
497,870
+208,029
| +72% | +$3.78M | 1.16% | 32 |
|
|
2024
Q2 | $5.51M | Buy |
289,841
+45,370
| +19% | +$862K | 0.74% | 46 |
|
|
2024
Q1 | $5.28M | Buy |
244,471
+11,529
| +5% | +$249K | 0.65% | 50 |
|
|
2023
Q4 | $4.05M | Buy |
232,942
+40,063
| +21% | +$696K | 0.57% | 56 |
|
|
2023
Q3 | $1.89M | Buy |
192,879
+7,801
| +4% | +$76.6K | 0.35% | 77 |
|
|
2023
Q2 | $1.02M | Buy |
185,078
+26,304
| +17% | +$145K | 0.18% | 86 |
|
|
2023
Q1 | $984K | Buy |
158,774
+23,932
| +18% | +$148K | 0.21% | 72 |
|
|
2022
Q4 | $2.06M | Buy |
134,842
+7,384
| +6% | +$113K | 0.55% | 57 |
|
|
2022
Q3 | $1.28M | Buy |
127,458
+101,208
| +386% | +$1.02M | 0.36% | 69 |
|
|
2022
Q2 | $311K | Buy |
+26,250
| New | +$311K | 0.11% | 75 |
|